Malaria is still a serious public health problem in Central Sulawesi. Only some parts of Donggala regency which it consists of the west and east coast areas have been included in
At present quinine is the antimalaria drug of choice in the treatment of chloroquine or multidrug resistant malaria and severe or complicated malaria. Artemisinine, a new antimalarial has been reported to be highly effective and of low toxicity. Therefore, artemisinine derivates (artesunate and artemether) need to be evaluated to have an alternative drug to be used in Indonesia. The study has b…
Community-based action can support health center programmes in reducing malaria morbidity and mortality and the improvement of health status. Robek was selected as a study site for evaluation of malaria control program through community participation which had been carried out since 1984. The various interventions involving community participation were applied as follows : case finding and mala…
The Indonesian Demographic and Health Survey (SDKI) was carried out in 1994. To maximize the usefulness and evaluate the televance of the data that been collected, extended analysis of immunizational status and morbidity of children underthree was performed. The purpose of his analysis was to assess the cases and proportion of the diseases or symptoms of children underthree who could show the K…
Treatment is aimed to cure the patients of their disease, rather than reducing parasite reservoirs. Chloroquine is the standard antimalarial drug for chemoprophylaxis, clinical malaria treatment and radical treatment. While sulfadoxine-pyrimenthamine and quinine are used as alternative antimalarial drugs for radical treatment of falciparum malaria in chloroquine resistant areas. Parenteral quin…